Exclusive Content

The Evolution of the Temp Controlled Supply Chain Industry

The Evolution of the Temp Controlled Supply Chain Industry

We sat down and spoke with with Rey Chern, Director, Engineering, Amgen; Lisa Sykes, Director of Quality Operations and Sterile Network, Merck; Bernard McGarvey, Senior Engineering Advisor, Eli Lilly and Company; Dan Mirica, Former Head of Global Logistics, Lonza Biologics; & Henrik Fröjdh, Associate Director Supply Chain Management, Merck & Co. on:

  • Temperature-controlled industry
  • The biggest disruptive technologies
  • Collaboration within the industry

Email enquiry@iqpc.com to request the video link sent to you via email.

McKesson on Canada’s Pharma Market

McKesson on Canada’s Pharma Market

Claude Jolicoeur, Director of Regulatory Affairs, McKesson met with us at our Annual event and discussed McKesson’s temperature controlled supply chain journey including:

  • Collaboration with carriers to keep temperatures within source conditions
  • Challenges with the last mile & saving cost in quality investments
  • Needs from data logging and RFID technology

Email enquiry@iqpc.com to request an emailed copy of the video.


Emerging Tech for the Pharma Supply Chain

Emerging Tech for the Pharma Supply Chain

We sat down with Dan Mirica, Former Head of Logistics, Lonza Biologics and discussed: 

  • blockchain applications for the pharma supply chain
  • challenges with drone implementation
  • the emergence of self driving trucks in Europe
Pharma Logistics Compliance Report

Pharma Logistics Compliance Report

This whitepapers covers the latest pharmaceutical logistics regulatory developments around the globe related to FMD, MHRA, ICH Q12, PACMP, GMP, DSCSA and more! Designed specifically to keep you up to date with key developments that will shape the compliance agenda. Highlights include:

  • GMP inspections international collaboration efforts
  • Supply Chain Security and Traceability – GPS
  • EMA regulations
  • Points to remember for your next GDP inspection
  • The latest on Human Drug Compounding Outsourcing Facilities regulations
  • An analysis of ICH Q12 concepts
  • The cost of Brexit and the road forward
  • An overview of EU's recently published report detailing the implementation of the Falsified Medicines Directive (FMD)